Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis

P. Andrews, Charles; Mohar, Dale; Salhi, Yacine; K. Tantry, Sudeesh

doi:10.1016/j.anai.2019.11.007

Public

Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis

Published in Annals of Allergy Asthma & Immunology • Nov 14, 2019

Authors:

Charles P. Andrews

Dale Mohar

Yacine Salhi

Abstract

BACKGROUND: GSP301 is an investigational fixed-dose combination nasal spray of olopatadine hydrochloride (antihistamine) and mometasone furoate (corticosteroid). OBJECTIVE: To evaluate efficacy and safety of GSP301 in patients with seasonal AR (SAR). METHODS: In this phase 2, double-blind, parallel-...

Subject

Mometasone furoate

Medicine

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!